Our study, likewise, demonstrated that TET2 remained an independent risk factor for thrombosis in ET patients with age, cardiovascular risk factors, and previous thrombosis as covariates, again an association not observed in PV. This evidence concerns the gene TET2 and acquired polycythemia vera.